Evolent Health (EVH) Appoints Tunde Sotunde to its Board

Go back to Evolent Health (EVH) Appoints Tunde Sotunde to its Board

Evolent Health (EVH) Reports In-Line Q3 EPS

November 3, 2021 4:42 PM EDT

Evolent Health (NYSE: EVH) reported Q3 EPS of ($0.03), in-line with the analyst estimate of ($0.03). Revenue for the quarter came in at $222.5 million versus the consensus estimate of $225.62 million.

GUIDANCE:

Evolent Health sees Q4 2021 revenue of $225-240 million, versus... More